Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease

Neuroreport. 2007 Dec 3;18(18):1997-2000. doi: 10.1097/WNR.0b013e3282f262ca.

Abstract

We have used the R6/2 mice to study cortico-striatal glutamatergic transmission by microdialysis in freely moving mice. Basal extracellular striatal glutamate concentrations were lower in R6/2 mice at 12 weeks of age, but not at 6 weeks of age, when neurological symptoms start to develop. In contrast, K-induced glutamate release was blunted in the striatum of R6/2 mice at both 6 and 12 weeks of age as compared with age-matched controls. We also found a substantial reduction in striatal pro-BDNF (brain derived neurotrophic factor) levels associated with no changes in the mature form of BDNF, as assessed by immunoblotting, in 12-week-old R6/2 mice, suggesting a reduced turnover rate of BDNF in the striatum of these mice. These data support the hypothesis of a cortico-striatal dysfunction in Huntington's disease.

MeSH terms

  • Aging / genetics
  • Aging / metabolism
  • Animals
  • Brain-Derived Neurotrophic Factor / metabolism*
  • Cerebral Cortex / metabolism*
  • Cerebral Cortex / physiopathology
  • Corpus Striatum / metabolism*
  • Corpus Striatum / physiopathology
  • Disease Models, Animal
  • Down-Regulation / physiology
  • Extracellular Fluid / metabolism
  • Female
  • Gene Expression Regulation / physiology
  • Glutamic Acid / metabolism*
  • Huntington Disease / genetics
  • Huntington Disease / metabolism*
  • Huntington Disease / physiopathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microdialysis
  • Neural Pathways / metabolism*
  • Neural Pathways / physiopathology
  • Synaptic Transmission / genetics

Substances

  • Brain-Derived Neurotrophic Factor
  • Glutamic Acid